论文部分内容阅读
目的探析盐酸利托君和硫酸镁在治疗先兆早产伴胎膜早破中的价值。方法在我院2015年2月~2017年3月产科收治的先兆早产伴胎膜早破患者中选取138例随机分成A组和B组,A组患者给予盐酸利托君保胎,B组患者选择硫酸镁保胎,对比两组患者的孕周延长时间、新生儿状况等。结果 A组孕妇在孕周延长时间、宫缩抑制时间优于B组,且A组孕妇的药物不良反应发生率低于B组孕妇,P<0.05;A组新生儿的存活率比B组高,且A组存活新生儿出生5min的Apgar评分高于B组,P<0.05。结论盐酸利托君治疗先兆早产伴胎膜早破效果确切,能延长患者的孕周,提高新生儿存活率,值得推广。
Objective To investigate the value of ritodrine hydrochloride and magnesium sulfate in the treatment of premature rupture of membranes with premature rupture of membranes. Methods 138 patients with threatened preterm labor and premature rupture of membranes in obstetrics admitted from February 2015 to March 2017 in our hospital were randomly divided into group A and group B. Group A received rituximab and group B Select magnesium sulfate miscarriage, gestational age compared to two groups of patients to extend the time, the status of newborns. Results The pregnant women in group A had longer gestational weeks and shorter duration of contractions than those in group B, and the incidence of adverse drug reactions in pregnant women in group A was lower than that in group B (P <0.05). The survival rate of neonates in group A was higher than that in group B , And the Apgar scores of newborns in group A at 5 min after birth were higher than those in group B (P <0.05). Conclusion Rituximab treatment of threatened premature rupture of membranes with premature rupture of membranes premature rupture of the exact results can prolong the gestational age of patients and improve neonatal survival rate, it is worth promoting.